Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
I've been losing about 2 lbs a week." This aligns with the average weight loss rate reported by many undergoing lipotropic injections
People taking orforglipron experienced substantial improvements in weight loss and blood sugar control compared to those taking a placebo, the study showed
However, Ozempic has been on the market much longer than Tirzepatide
The treatment is administered via a once-weekly subcutaneous injection, typically in the abdomen or thigh
eGFR (estimated glomerular filtration rate) estimates how well kidneys are filtering
$50/month copay for eligible GLP-1s, including Wegovy, Zepbound (KwikPen), and the new oral pill Foundayo (orforglipron)*^ Available to Medicare Part D members who meet certain BMI and health criteria* Program runs July 1, 2026 December 31, 2027^ *For eligible Medicare Part D patients with qualifying GLP-1 medication prescription for weight management
